{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T10:26:06Z","timestamp":1771237566645,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.ucl.2010.04.010","type":"journal-article","created":{"date-parts":[[2010,8,3]],"date-time":"2010-08-03T04:44:47Z","timestamp":1280810687000},"page":"467-474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Chemotherapy for Penile and Urethral Carcinoma"],"prefix":"10.1016","volume":"37","author":[{"given":"Edouard J.","family":"Trabulsi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Hoffman-Censits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ucl.2010.04.010_bib1","first-page":"225","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ucl.2010.04.010_bib2","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0022-5347(17)38068-0","article-title":"Squamous cell carcinoma of the penis: accuracy of tumor, nodes and metastasis classification system, and role of lymphangiography, computerized tomography scan and fine needle aspiration cytology","volume":"146","author":"Horenblas","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2010.04.010_bib3","first-page":"1244","article-title":"Surgical treatment of invasive squamous cell carcinoma of the penis: retrospective analysis of 350 cases","volume":"151","author":"Ornellas","year":"1994","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2010.04.010_bib4","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.eururo.2007.02.006","article-title":"Neoadjuvant chemotherapy in advanced penile carcinoma","volume":"52","author":"Leijte","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2010.04.010_bib5","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3109\/02841868809094366","article-title":"Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis","volume":"27","author":"Pizzocaro","year":"1988","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ucl.2010.04.010_bib6","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.juro.2006.11.038","article-title":"Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma","volume":"177","author":"Bermejo","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2010.04.010_bib7","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0022-5347(05)68815-5","article-title":"Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study","volume":"161","author":"Haas","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2010.04.010_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0022-5347(17)40590-8","article-title":"cis-Diamminedichloroplatinum in the treatment of advanced epidermoid carcinoma of the penis: a Southwest Oncology Group Study","volume":"141","author":"Gagliano","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2010.04.010_bib9","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.eururo.2008.07.014","article-title":"Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results","volume":"55","author":"Pizzocaro","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2010.04.010_bib10","first-page":"359","article-title":"Advanced penile carcinoma","volume":"170","author":"Culkin","year":"2003","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.ucl.2010.04.010_bib11","article-title":"EAU Penile Cancer Guidelines 2009","author":"Pizzocaro","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2010.04.010_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000480874","article-title":"Up-to-date management of carcinoma of the penis","volume":"32","author":"Pizzocaro","year":"1997","journal-title":"Eur Urol"},{"key":"10.1016\/j.ucl.2010.04.010_bib13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1464-410X.1993.tb16273.x","article-title":"Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis","volume":"72","author":"Ravi","year":"1993","journal-title":"Br J Urol"},{"key":"10.1016\/j.ucl.2010.04.010_bib14","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1464-410X.2006.06496.x","article-title":"Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma","volume":"98","author":"Hakenberg","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.ucl.2010.04.010_bib15","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0022-5347(17)62235-3","article-title":"Bleomycin treatment of the tumors of penis and scrotum","volume":"102","author":"Ichikawa","year":"1969","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2010.04.010_bib16","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1464-410X.1983.tb03366.x","article-title":"Adjuvant treatment using bleomycin in squamous cell carcinoma of penis: study of 19 cases","volume":"55","author":"Maiche","year":"1983","journal-title":"Br J Urol"},{"key":"10.1016\/j.ucl.2010.04.010_bib17","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/1097-0142(197911)44:5<1563::AID-CNCR2820440503>3.0.CO;2-S","article-title":"Cis-diamminedichloride platinum II (DDP) in the treatment of penile carcinoma","volume":"44","author":"Sklaroff","year":"1979","journal-title":"Cancer"},{"key":"10.1016\/j.ucl.2010.04.010_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0022-5347(17)56360-0","article-title":"Metastatic carcinoma of the penis: complete remission after high dose methotrexate chemotherapy","volume":"122","author":"Garnick","year":"1979","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2010.04.010_bib19","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/1097-0142(19800115)45:2<214::AID-CNCR2820450203>3.0.CO;2-K","article-title":"Methotrexate in the treatment of penile carcinoma","volume":"45","author":"Sklaroff","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.ucl.2010.04.010_bib20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0022-5347(17)49693-5","article-title":"Sequential trials of methotrexate, cisplatin and bleomycin for penile cancer","volume":"132","author":"Ahmed","year":"1984","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2010.04.010_bib21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/1097-0142(19900201)65:3<433::AID-CNCR2820650310>3.0.CO;2-G","article-title":"Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas","volume":"65","author":"Hussein","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.ucl.2010.04.010_bib22","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0022-5347(17)37327-5","article-title":"Cisplatin and 5-fluorouracil in advanced cancer of the penis","volume":"147","author":"Shammas","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2010.04.010_bib23","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0022-5347(17)38069-2","article-title":"Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract","volume":"146","author":"Dexeus","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2010.04.010_bib24","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/annonc\/mdn149","article-title":"A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992)","volume":"19","author":"Theodore","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ucl.2010.04.010_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.urolonc.2007.10.015","article-title":"Cisplatin and gemcitabine in the management of metastatic penile cancer","volume":"27","author":"Power","year":"2009","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ucl.2010.04.010_bib26","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.urology.2003.12.026","article-title":"Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer","volume":"63","author":"Joerger","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.ucl.2010.04.010_bib27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/CAD.0b013e328329a293","article-title":"Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients","volume":"20","author":"Di Lorenzo","year":"2009","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ucl.2010.04.010_bib28","doi-asserted-by":"crossref","unstructured":"Nicolai N, Necchi A, Piva L, et\u00a0al. A combination of cisplatin and 5-fluorouracil plus a taxane for advanced squamous-cell carcinoma (SCC) of the penis: a single-institution series [abstract #255]. In: American Society of Clinical Oncology Genitourinary Cancers Symposium, San Francisco (CA), March 5\u20137, 2010.","DOI":"10.1016\/S1569-9056(10)60552-0"},{"key":"10.1016\/j.ucl.2010.04.010_bib29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ucl.2010.04.010_bib30","doi-asserted-by":"crossref","unstructured":"Carthon BC, Pettaway CA, Pagliaro LC. Epidermal growth factor receptor (EGFR) targeted therapy in advanced metastatic squamous cell carcinoma (AMSCC) of the penis [abstract #254]. In: American Society of Clinical Oncology Genitourinary Cancers Symposium, San Francisco (CA), March 5\u20137, 2010.","DOI":"10.1200\/jco.2010.28.15_suppl.e15022"},{"key":"10.1016\/j.ucl.2010.04.010_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ucl.2010.04.010_bib32","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa071834","article-title":"Cetuximab for the treatment of colorectal cancer","volume":"357","author":"Jonker","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ucl.2010.04.010_bib33","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1464-410x.2001.00126.x","article-title":"Clear cell adenocarcinoma of the female urethra showing strong immunostaining for prostate-specific antigen","volume":"87","author":"Kawano","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.ucl.2010.04.010_bib34","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1016\/S0022-5347(01)67352-X","article-title":"Clear cell adenocarcinoma arising from a urethral diverticulum","volume":"153","author":"Seballos","year":"1995","journal-title":"J Urol"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014310000315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014310000315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:21:58Z","timestamp":1758806518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014310000315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0094014310000315"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2010.04.010","relation":{},"ISSN":["0094-0143"],"issn-type":[{"value":"0094-0143","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemotherapy for Penile and Urethral Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2010.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}